How Would You Change the Constitution?
I asked scholars, podcasters, and passersby how they'd change the nation's founding charter. Here's what they told me.
I asked scholars, podcasters, and passersby how they'd change the nation's founding charter. Here's what they told me.
The agency’s policies would boost the black market and smoking-related deaths.
Time for a new Operation Warp Speed?
Senators asked for an investigation since the "sweet, chocolaty taste may encourage consumers to eat well over a recommended quantity of melatonin."
Bureaucrats say they want to save lives. But they're moving to block a tool that is proven to help smokers quit entirely.
The FDA could work with the Department of Justice to sue states over mifepristone bans. But should it?
Regulatory uncertainty is keeping the seaweed market from reaching its full potential.
What was once a classic Silicon Valley success story has become the victim of an intensely ideological war on nicotine.
Plus: Supreme Court rules on school choice and criminal justice reform, Louisiana's trigger law criminalizes abortion at any stage, and more...
Hulu's limited TV series on Elizabeth Holmes shows how regulators failed to catch massive, dangerous medical fraud.
Everybody knows what almond, oat, and soy milk are. We don’t need the FDA’s intervention, no matter what the dairy lobby claims.
This crisis is the result of protectionism, regulation, and central planning.
Governments can't plan economies, but can disrupt them.
Plus: Resurrecting an extinct tiger, reviewing the police response to the Uvalde shooting, and more...
The Georgetown professor isn't a toy lover—he's trying to convey a philosophical idea about the nature of free will and the capacity of humans to remake the world around them.
Markets work if you let them. The Biden administration and Congress should remove supply restraints on baby formula that never made any sense in the first place.
Plus: Supreme Court sides with Ted Cruz in campaign finance case, gender quota for corporate boards ruled unconstitutional, and more...
"The knot in getting that product into the U.S. isn't safety, it's a regulatory issue," says Peter Pitts.
Plus: Netflix defends artistic expression, perspectives on the baby formula shortage, and more...
Trade restrictions and over-zealous FDA regulation are a big part of the problem, but there's more.
The activists who say otherwise are wrong on the costs and wrong on the science.
Plus: Trusting the science is now an explicitly partisan issue, stocks are still plummeting, and more...
In a move that is likely to undermine public health, the agency warns that products containing synthetic nicotine "will be subject to FDA enforcement."
The proposed rule, which targets the cigarettes that black smokers overwhelmingly prefer, will harm the community it is supposed to help.
Menthols aren’t harder to quit than other cigarettes.
The Stanford professor and Great Barrington Declaration coauthor stands up to COVID-19 autocrats and disastrous lockdowns by following the science.
The anti-lockdown Stanford public health professor on being attacked by Fauci, the loss of trust in medical experts, and how to save science going forward.
Among experts on food safety, the consensus is that the FDA's food division isn't functional.
The agency's obsession with adolescent vaping is driving decisions that undermine public health.
The state's regulators plan to start accepting applications from manufacturers and "service centers" on January 2.
Meanwhile the FDA dawdles over second boosters as new COVID-19 wave approaches
It’s likely to happen any day now.
The experience in Texas shows that workarounds pose daunting obstacles to such laws.
A spending bill provision would redefine "tobacco products" to include products that have nothing to do with tobacco.
Robert Califf must demand transparency and accountability from the bureaucrats.
From the CDC to the FDA, there are too many missteps to list.
Not only won’t they blow your mind, but they may even save it (sometimes legally).
While the rule is set to go into effect this weekend, companies are scrambling to figure out how to cover or reimburse people for the tests.
Why? A better question was why they were ever involved in the first place.
One step closer to solving the organ shortage crisis?
Plus: Waiting lists for public defenders, inflation boogeymen, and more...
Plus: Questioning paranoia about smartphones and attention spans, new small business creation is thriving, and more...
It's another case of bureaucratic incompetence as the omicron wave surges.
Plus: Criminals have stolen $100 billion in pandemic relief funds, and colleges are planning to go virtual once again.
Federal regulators have permanently lifted a requirement that mifepristone be dispensed in person.